InspireMD (NSPR) Cash from Investing Activities Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -397.90% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -514.25% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -211.17% |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | -647.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -647.62% |
| Sep 30, 2025 | 227.46% |
| Jun 30, 2025 | -3.34% |
| Mar 31, 2025 | -64.67% |
| Dec 31, 2024 | 22,994.44% |
| Sep 30, 2024 | -192.77% |
| Jun 30, 2024 | 120.48% |
| Mar 31, 2024 | 8.27% |
| Dec 31, 2023 | -100.93% |
| Sep 30, 2023 | 131.88% |
| Jun 30, 2023 | -1,541.10% |
| Mar 31, 2023 | 6,944.62% |
| Dec 31, 2022 | 111.08% |
| Sep 30, 2022 | 111.39% |
| Jun 30, 2022 | 2,173.33% |
| Mar 31, 2022 | -170.83% |
| Dec 31, 2021 | 1,870.19% |
| Sep 30, 2021 | -49,255.10% |
| Jun 30, 2021 | -190.32% |
| Mar 31, 2021 | -700.00% |
| Dec 31, 2020 | -50.72% |
| Sep 30, 2020 | 47.87% |
| Jun 30, 2020 | 73.95% |
| Mar 31, 2020 | 97.14% |
| Jun 30, 2019 | -310.34% |
| Mar 31, 2019 | -775.00% |
| Jun 30, 2018 | 25.64% |
| Mar 31, 2018 | 92.31% |
| Dec 31, 2017 | -227.27% |
| Sep 30, 2017 | -200.00% |
| Jun 30, 2017 | -295.00% |
| Mar 31, 2017 | -273.33% |
| Dec 31, 2016 | 65.63% |
| Jun 30, 2016 | 122.22% |
| Mar 31, 2016 | 918.18% |
| Mar 31, 2015 | 67.65% |
| Mar 31, 2014 | 54.05% |
| Sep 30, 2013 | -92.98% |
| Mar 31, 2013 | -54.17% |
| Dec 31, 2012 | -186.62% |
| Sep 30, 2012 | -121.59% |
| Mar 31, 2012 | 52.94% |
| Dec 31, 2011 | 2,142.86% |
| Sep 30, 2011 | 442.86% |